Coastal Bridge Advisors LLC bought a new position in Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, Holdings Channel reports. The fund bought 5,958 shares of the conglomerate’s stock, valued at approximately $4,290,000.
A number of other hedge funds also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in Danaher during the 2nd quarter valued at approximately $10,492,520,000. Norges Bank purchased a new stake in shares of Danaher during the 4th quarter worth approximately $2,177,106,000. Jupiter Topco LLC purchased a new stake in shares of Danaher during the 2nd quarter worth approximately $1,456,317,000. Generation Investment Management LLP bought a new position in shares of Danaher during the 2nd quarter valued at approximately $1,287,949,000. Finally, Bank of America Corp DE bought a new position in shares of Danaher during the 2nd quarter valued at approximately $993,846,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Stock Performance
NYSE DHR opened at $215.74 on Friday. The business’s 50 day moving average price is $198.69 and its 200-day moving average price is $192.35. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a market cap of $151.67 billion, a P/E ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.
Analysts Set New Price Targets
DHR has been the topic of several research reports. DZ Bank initiated coverage on shares of Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target on the stock. Royal Bank Of Canada increased their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Finally, Evercore restated an “outperform” rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.
Check Out Our Latest Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
